Fri, May 9, 7:36 PM (13 days ago)
**Cannabis Bioscience International Holdings, Inc. (CBIS) - Q1 2025 Financial Summary** Cannabis Bioscience International Holdings, Inc. (CBIS) filed an amendment to its Q1 2025 10-Q, correcting errors in financial statements and updating share counts. Key financial metrics and trends are as follows: **Financial Health & Performance:** - **Revenue:** Q1 2025 revenue was $14,931, down from $36,411 in Q1 2024, primarily due to a decrease in clinical trial revenues. - **Gross Profit:** Q1 2025 gross loss was $4,465, compared to a gross profit of $24,602 in Q1 2024. - **Operating Loss:** Q1 2025 operating loss was $129,234, down from $159,971 in Q1 2024. - **Net Loss:** Q1 2025 net loss was $181,243, compared to $209,192 in Q1 2024. **Profit Margins:** - **Gross Margin:** Q1 2025 gross margin was -29.9%, compared to 67.5% in Q1 2024. - **Operating Margin:** Q1 2025 operating margin was -865.8%, compared to -438.7% in Q1 2024. **Cash Flow:** - **Net Cash Used in Operations:** Q1 2025 saw $185,315 used in operations, down from $304,943 in Q1 2024. - **Net Cash Provided by Financing Activities:** Q1 2025 saw $185,108 provided by financing activities, down from $296,824 in Q1 2024. **Earnings Changes:** - **Earnings per Share (EPS):** Q1 2025 EPS was -$0.00002, compared to -$0.00002 in Q1 2024. **Trends & Uncertainties:** - CBIS faces substantial doubt about its ability to continue as a going concern due to recurring losses, negative working capital, and negative cash flows from operations. - The company's ability to continue operations depends on successful execution of its operating plan, including expanding operations and raising debt or equity financing. - CBIS has a history of high operating expenses, particularly in professional fees and contract labor. **Future Operations Impact:** - CBIS plans to increase sales of existing services, introduce new services, and raise additional capital to fund its business and repay debts. - The company's success is uncertain, and it may need to take measures to remain a going concern if adequate capital cannot be obtained. **Disclosure Controls & Procedures:** - CBIS's management concluded that its disclosure controls and procedures were not effective as of February 28, 2025. **Risk Factors:** - CBIS is a smaller reporting company and is not required to provide information under this item, but it faces significant risks related to its financial condition and ability to continue as a going concern.